Clinical Trial Detail

NCT ID NCT02083653
Title Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements yes
Sponsors EMD Serono
Indications

colorectal cancer

Therapies

SYM004

Fluorouracil

Capecitabine

Age Groups: adult

Additional content available in CKB BOOST